Alakananda Basu

14.7k total citations · 1 hit paper
109 papers, 5.1k citations indexed

About

Alakananda Basu is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Alakananda Basu has authored 109 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 34 papers in Oncology and 13 papers in Physiology. Recurrent topics in Alakananda Basu's work include Cell death mechanisms and regulation (36 papers), Protein Kinase Regulation and GTPase Signaling (28 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). Alakananda Basu is often cited by papers focused on Cell death mechanisms and regulation (36 papers), Protein Kinase Regulation and GTPase Signaling (28 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). Alakananda Basu collaborates with scholars based in United States, India and Canada. Alakananda Basu's co-authors include John S. Lazo, Usha Sivaprasad, Savitha Sridharan, Kirti Jain, Dean H. Hamer, Susan L. Kelley, Beverly A. Teicher, Miles P. Hacker, Robert H. Glew and Giridhar R. Akkaraju and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Alakananda Basu

107 papers receiving 5.1k citations

Hit Papers

Overexpression of Metallothionein Confers Resistance to A... 1988 2026 2000 2013 1988 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
    1988 524 citations Alakananda Basu, John S. Lazo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alakananda Basu United States 36 3.3k 1.4k 667 606 457 109 5.1k
Prakash G. Jagtap United States 19 2.9k 0.9× 1.7k 1.2× 679 1.0× 402 0.7× 428 0.9× 41 5.0k
Moulay A. Alaoui‐Jamali Canada 42 3.1k 1.0× 1.3k 0.9× 378 0.6× 792 1.3× 463 1.0× 138 4.8k
Alexandru Almasan United States 45 4.4k 1.3× 1.9k 1.3× 671 1.0× 1.0k 1.7× 469 1.0× 96 6.5k
Melchiorre Cervello Italy 44 3.4k 1.0× 1.3k 0.9× 690 1.0× 1.1k 1.8× 380 0.8× 137 6.0k
Gabriella D’Orazi Italy 43 3.8k 1.2× 2.3k 1.7× 917 1.4× 1.5k 2.5× 540 1.2× 131 6.3k
F. Michael Yakes United States 15 3.4k 1.1× 2.3k 1.6× 339 0.5× 679 1.1× 269 0.6× 20 5.9k
Marie‐Thérèse Dimanche‐Boitrel France 34 2.8k 0.9× 992 0.7× 370 0.6× 567 0.9× 320 0.7× 78 3.8k
Brigitte Marian Austria 36 2.3k 0.7× 1.1k 0.8× 277 0.4× 664 1.1× 252 0.6× 111 3.8k
Philippe Juin France 36 4.1k 1.3× 1.1k 0.8× 1.2k 1.8× 722 1.2× 528 1.2× 93 5.6k
Juliane M. Jürgensmeier United States 30 3.7k 1.1× 1.3k 0.9× 493 0.7× 738 1.2× 269 0.6× 69 5.4k

Countries citing papers authored by Alakananda Basu

Since Specialization
Citations

This map shows the geographic impact of Alakananda Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alakananda Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alakananda Basu more than expected).

Fields of papers citing papers by Alakananda Basu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alakananda Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alakananda Basu. The network helps show where Alakananda Basu may publish in the future.

Co-authorship network of co-authors of Alakananda Basu

This figure shows the co-authorship network connecting the top 25 collaborators of Alakananda Basu. A scholar is included among the top collaborators of Alakananda Basu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alakananda Basu. Alakananda Basu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basu, Alakananda & Zhenyu Xuan. (2024). p21Waf1/Cip1 Is a Novel Downstream Target of 40S Ribosomal S6 Kinase 2. Cancers. 16(22). 3783–3783. 1 indexed citations
2.
Basu, Alakananda. (2021). The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy. Pharmacology & Therapeutics. 230. 107943–107943. 119 indexed citations
3.
Shapiro, R, et al.. (2012). The Banff 2009 Working Proposal for Polyomavirus Nephropathy: A Critical Evaluation of Its Utility as a Determinant of Clinical Outcome. American Journal of Transplantation. 12(4). 907–918. 61 indexed citations
4.
Basu, Alakananda, et al.. (2010). Cellular Responses to Cisplatin‐Induced DNA Damage. Journal of Nucleic Acids. 2010(1). 426 indexed citations
5.
Basu, Alakananda, et al.. (2010). Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression. Cancer Chemotherapy and Pharmacology. 66(5). 945–952. 14 indexed citations
6.
Basu, Alakananda, Savitha Sridharan, & Shalini Persaud. (2009). Regulation of protein kinase Cδ downregulation by protein kinase Cε and mammalian target of rapamycin complex 2. Cellular Signalling. 21(11). 1680–1685. 11 indexed citations
7.
Basu, Alakananda, Shalini Persaud, & Usha Sivaprasad. (2008). Chapter 8 Manipulation of PKC Isozymes by RNA Interference and Inducible Expression of PKC Constructs. Methods in enzymology on CD-ROM/Methods in enzymology. 446. 141–157. 2 indexed citations
8.
Lu, Dongmei, et al.. (2007). Protein kinase C-ε protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation. APOPTOSIS. 12(10). 1893–1900. 30 indexed citations
9.
10.
Basu, Alakananda, et al.. (2005). Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cδ. Biochemical and Biophysical Research Communications. 334(4). 1068–1073. 62 indexed citations
11.
Keven, Kenan, Alakananda Basu, A. Marcos, et al.. (2004). Clostridium difficile colitis in patients after kidney and pancreas–kidney transplantation. Transplant Infectious Disease. 6(1). 10–14. 73 indexed citations
12.
Basu, Alakananda. (2003). Involvement of protein kinase C‐δ in DNA damage‐induced apoptosis. Journal of Cellular and Molecular Medicine. 7(4). 341–350. 93 indexed citations
13.
Basu, Alakananda & Giridhar R. Akkaraju. (2003). Compartmentalized Protein Kinase C Activation in Ovarian Carcinoma Cells. Humana Press eBooks. 39. 621–631.
14.
Basu, Alakananda, Sanghamitra Mohanty, & Baohua Sun. (2001). Differential Sensitivity of Breast Cancer Cells to Tumor Necrosis Factor-α: Involvement of Protein Kinase C. Biochemical and Biophysical Research Communications. 280(3). 883–891. 39 indexed citations
15.
Akkaraju, Giridhar R. & Alakananda Basu. (2000). Overexpression of Protein Kinase C-η Attenuates Caspase Activation and Tumor Necrosis Factor-α-Induced Cell Death. Biochemical and Biophysical Research Communications. 279(1). 103–107. 33 indexed citations
16.
Basu, Alakananda, et al.. (2000). Regulation of Bcl2 phosphorylation by stress response kinase pathway.. International Journal of Oncology. 16(3). 497–500. 26 indexed citations
17.
Basu, Alakananda. (1998). The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Molecular Human Reproduction. 4(12). 1099–1109. 422 indexed citations
18.
Basu, Alakananda. (1993). The potential of protein kinase C as A target for anticancer treatment. Pharmacology & Therapeutics. 59(3). 257–280. 178 indexed citations
19.
Basu, Alakananda, Alan P. Kozikowski, & John S. Lazo. (1992). Structural requirements of lyngbyatoxin A for activation and downregulation of protein kinase C. Biochemistry. 31(15). 3824–3830. 15 indexed citations
20.
Basu, Alakananda, Gerard H. De Haas, Ruud Dijkman, et al.. (1988). Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates. Archives of Biochemistry and Biophysics. 262(1). 345–353. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prakash G. Jagtap Breakdown of academic impact, for papers by Moulay A. Alaoui‐Jamali Breakdown of academic impact, for papers by Alexandru Almasan Breakdown of academic impact, for papers by Melchiorre Cervello Breakdown of academic impact, for papers by Gabriella D’Orazi Breakdown of academic impact, for papers by F. Michael Yakes Breakdown of academic impact, for papers by Marie‐Thérèse Dimanche‐Boitrel Breakdown of academic impact, for papers by Brigitte Marian Breakdown of academic impact, for papers by Philippe Juin Breakdown of academic impact, for papers by Juliane M. Jürgensmeier
Rankless by CCL
2026